Teva Appoints New President, CEO

Jan 09, 2014


Teva Pharmaceutical Industries announced that Erez Vigodman, 54, has been appointed President and Chief Executive Officer, effective February 11, 2014. Vigodman will succeed acting President and CEO Eyal Desheh, who will return to his previous position as Group EVP and Chief Financial Officer of the company. Vigodman is currently President and CEO of Makhteshim Agan Industries (MAI), the world’s leading generic agrochemical company. He will retain that position until February 6. Read the full press release